Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.
A DNA nano-harvester stays on its track inside tumor cells, measuring cancer aggressiveness by detecting a key microRNA ...
Interesting Engineering on MSN
AI creates artificial animals that over time develop functioning vision without instruction
Researchers in Sweden created artificial animals that over time develop functioning vision from scratch ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...
Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
This time around, the group recruited 10 GWL dogs and 21 non-GWL dogs, all border collies, since this is the most common breed to fall into the GWL category. They compiled a list of eight toys: two ...
Feb. 19, 2026 A major breakthrough could help save the world’s bananas from a devastating disease. Scientists have discovered the exact genetic region in a wild banana that provides resistance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results